Knight CJ. A systematic review of the efficacy of recombinant activated factor VII and activated prothrombin complex concentrate in the on-demand treatment of minor to moderate bleeding episodes for haemophilia patients with inhibitors. Poster presented at the 2008 ISPOR 11th Annual European Congress; December 29, 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A628.
Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life and productivity of patients with hemophilia and inhibitors. Poster presented at the European Conference of the International Society for Pharmacoeconomics and Outcomes Research; November 2008.
Wolowacz SE, Hess N, Brennan VK, Monz BU, Plumb JM. Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years. Curr Med Res Opin. 2008 Oct 1;24(10):2993-3006.
Candrilli S, Balkrishnan R, O'Brien SH. The effect of injury severity on the incidence and resource utilization-related outcomes of deep vein thrombosis among pediatric trauma admissions in the United States. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A246-7.
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Relative mortality and epoetin alfa dose in hemodialysis patients - Reply. Am J Kidney Dis. 2008 May 1;51(5):865-6.
Lee WC, Joshi AV, Woolford S, Sumner M, Brown TM, Hadker N, Pashos CL. Physicians' preferences towards coagulation factor concentrates in the treatment of haemophilia with inhibitors: a discrete choice experiment. Haemophilia. 2008 May 1;3(14):454-65.
Lee WC, Joshi AV, Brown TM, Pashos CL. Patient- and caregiver-reported preferences for characteristics of treatments for hemophilia patients with inhibitors. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A164-5.
Pearson IV, Johnson KI. A cost minimization analysis of epoetin zeta for the treatment of anemia associated with chronic kidney disease. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. [abstract] Value Health. 2008 May; 11(3):A304.
Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life of patients with hemophilia and inhibitors. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A154.
Anthony MS, Clarkson TB. Association between plasma isoflavone and plasma lipoprotein concentrations. Presented at the Symposium on Phytoestrogen Research Methods; September 1997. Tucson, AZ.
Martin AV, Coffield K. Hemophilia: information for educators and communication disorders specialists. Poster presented at the American Speech-Language-Hearing Association; April 1997. [abstract] Perspect Lang Learn Educ. 1997 Apr; 4:13-5.